Oculis Holding AG (OCS) News
Follow Oculis Holding AG (OCS) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 5 public stories across 4 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Oculis Completes Randomization in Licaminlimab Registrational Trial
Oculis said randomization is complete in the PREDICT-1 registrational trial of licaminlimab for TNFR1-mediated dry eye disease.
EQUITY | Oct 19, 2026, 06:00 AM UTC
M
OCS starts PIONEER-1 trial after first Privosegtor patient treated
OCS says it has treated the first patient in its PIONEER-1 registrational trial of Privosegtor for optic neuritis.
EQUITY | Aug 24, 2026, 08:00 AM UTC
H
Oculis To Submit IND For Privosegtor In Acute MS Relapses In Q4 2026, Backed By Positive FDA Pre-IND Guidance And Prior Optic Neuritis Data
The FDA Division of Neurology provided positive feedback supporting a regulatory pathway for Privosegtor in acute multiple sclerosis (MS) relapses, addressing a significant unmet medical need The FDA confirmed that exist
REGULATION | Aug 03, 2026, 08:01 AM UTC
L
OCS - Oculis Announces Positive FDA Pre-IND Feedback Supporting Privosegtor Development Strategy for Treatment of Acute Multiple Sclerosis R
OCS - Oculis Announces Positive FDA Pre-IND Feedback Supporting Privosegtor Development Strategy for Treatment of Acute Multiple Sclerosis Relapses
REGULATION | Aug 03, 2026, 08:00 AM UTC
H
Intuitive Surgical, Netflix And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
U.S. stock futures were lower this morning, with the Nasdaq 100 futures falling around 2% on Friday. Shares of Intuitive Surgical Inc (NASDAQ: ISRG ) fell sharply in pre-market trading after the company reported second-q
EARNINGS | Jul 17, 2026, 12:02 PM UTC